Not cancer · Austria
Alzheimer disease
How is it diagnosed today? There is no simple, reliable test. The doctor checks your general health, may order blood tests and ask about your medicines to rule out other causes, and asks you to do some memory and thinking tasks. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.5 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Symptom medicines (e.g. donepezil) plus support. NHS
5 medicines are approved for this disease in Austria:
- Donanemab (Kisunla) – approved in 2025
- Lecanemab (Leqembi) – approved in 2025
- Memantine (Memantine Mylan, Memantine ratiopharm, memantine hydrochloride) – approved in 2013
- Memantine hydrochloride (Memantine Merz) – approved in 2012
- Rivastigmine (Rivastigmine, Exelon, Exelon Patch) – approved in 2009
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (7)
- Benzgalantamine (Zunveyl) – approved for it in the US
- Brexpiprazole (Rexulti) – approved for it in the US
- Dextromethorphan and bupropion (Auvelity) – approved for it in the US
- Donepezil (Aricept, Donepezil Sandoz) – approved for it in the US, Switzerland, and France
- Galantamine (Galantamine, Reminyl PR, Galantamine Biogaran Lp) – approved for it in the US, Switzerland, and France
- Memantine and donepezil (Namzaric) – approved for it in the US
- Risperidone (Risperdal, Risperidone Eg) – approved for it in France
Being tested in people
5 open trials in Austria, 622 worldwide. See the trials
- ACP-204 (Phase 3)
- AR1001 (Phase 3)
- Atomoxetine (Phase 3)
- buntanetap/posiphen (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 2 were in animals and 1 in the lab. See them
No proof it works
We checked 13 things people say help with this disease against the research. See how far each has been tested
No trial in people on record yet:
- Mistletoe extract (only single reports in people)
- Hyperthermia (animal studies only)
- Ivermectin (animal studies only)
- Dichloroacetate (DCA) (lab studies only)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
2 open trials in Austria with these filters, and 1 opening soon or by invitation
Tests a personalized lifestyle program for older adults at risk of memory decline
NCT07376135 · ClinicalTrials.gov
- Graz – Medical University of Innsbruck
- Innsbruck – Medical University of Innsbruck
- Vienna – Medical University of Vienna
Ages 55 to 75
Contact the trial teamScanning a Transport Protein in Healthy Adults and Alzheimer's Patients
2024-517851-11-00 · EU Clinical Trials Register
- Vienna – Medical University of Vienna
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStudying how a brain scan tracer moves in healthy adults and people with Alzheimer's
2024-517875-19-00 · EU Clinical Trials Register
- Vienna – Medical University of Vienna
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
Available abroad (370 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Brain scans of synapses, tau and inflammation in Alzheimer's, healthy adults and centenarians
NCT07906054 · ClinicalTrials.gov
Countries: Belgium
- Leuven, Belgium – University Hospitals Leuven
Age 18 and over
Contact the trial teamTests a plant-based supplement's effect on memory and thinking in older adults
NCT07226674 · ClinicalTrials.gov
Countries: United Kingdom
- Coleraine, United Kingdom – Ulster University, Human Intervention Studies Unit
Age 50 and over
Contact the trial teamEye pupil measurements in virtual reality for memory problems and depression
NCT07402356 · ClinicalTrials.gov
Countries: Germany
- München, Germany – Max Planck Institute of Psychiatry
Ages 18 to 80
Contact the trial teamTear tests to look for Alzheimer's disease markers
NCT06661564 · ClinicalTrials.gov
Countries: France
- Tours, France – CHRU de Tours
Age 18 and over
Contact the trial teamComparing Two Types of Strength Training in Older Adults With Alzheimer's Disease
NCT07918417 · ClinicalTrials.gov
Countries: Spain
- Valladolid, Spain – Miguel de Cervantes European University
Age 60 and over
Contact the trial teamTesting Movement Training and Devices in People With Movement Disorders and Healthy Adults
NCT07066137 · ClinicalTrials.gov
Countries: Italy
- Messina, Italy – IRCCS Centro Neurolesi Bonino Pulejo
Ages 18 to 70
Contact the trial teamUsing AI to analyze speech in Alzheimer's, Parkinson's and other dementias
NCT07906769 · ClinicalTrials.gov
Countries: Italy
- Bari, Italy – Istituti Clinici Scientifici Maugeri IRCCS Bari
Ages 40 to 90
Contact the trial teamBuilding an Italian test of famous-face recognition for people with stroke or dementia
NCT07911878 · ClinicalTrials.gov
Countries: Italy
- Bari, Italy – Istituti Clinici Scientifici Maugeri IRCCS Bari
- Castel Goffredo, Italy – IRCCS Maugeri Castel Goffredo
- Lumezzane, Italy – IRCCS Maugeri Lumezzane
Ages 40 to 85
Contact the trial teamEye Imaging to Study Retina Changes in People With Memory Impairment
NCT04389437 · ClinicalTrials.gov
Countries: France
- Paris, France – Hôpital Fondation A. de Rothschild
Age 18 and over
Contact the trial teamSpeech and language therapy study for people with primary progressive aphasia
NCT06739967 · ClinicalTrials.gov
Countries: Italy
- Bari, Italy – Istituti Clinici Scientifici Maugeri IRCCS
- Milan, Italy – IRCCS Ospedale San Raffaele
Ages 40 to 85
Contact the trial teamStudies biomarkers that may predict Alzheimer's in people with inherited mutations
NCT00869817 · ClinicalTrials.gov
Countries: Germany, Spain, United Kingdom and 10 more
- Munich, Germany – German Center for Neurodegenerative Diseases (DZNE) Munich, and University Hospital Ludwig-Maximilians-Universitat (LMU) Munich
- Tübingen, Germany – German Center for Neurodegenerative Diseases (DZNE) Tübingen and Hertie-Institute for Clinical Brain Research, University of Tübingen
- Barcelona, Spain – Hospital Clinic Barcelona
Age 18 and over
Contact the trial teamSpermidine supplement and sleep in older adults with memory concerns or mild cognitive impairment
NCT07383311 · ClinicalTrials.gov
Countries: Germany
- Greifswald, Germany – Department of Neurology, University Medicine Greifswald
Ages 55 to 75
Contact the trial teamStudies taste changes in people with memory and thinking problems
NCT05888961 · ClinicalTrials.gov
Countries: France
- Dijon, France – Chu Dijon Bourgogne
Age 18 and over
Contact the trial teamRemote digital tracking of early memory and thinking changes
NCT04701177 · ClinicalTrials.gov
Countries: Spain, Greece
- Barcelona, Spain – Hospital Clinic Barcelona
- Corfu, Greece – Ionian University
- Thessaloniki, Greece – Panhellenic Federation of Alzheimer's Disease and Related Disorders
Age 45 and over
Contact the trial teamRepetitive behaviors in people with Alzheimer's disease and memory loss
NCT07732842 · ClinicalTrials.gov
Countries: France
- Limoges, France – Esquirol Hospital Center
Age 18 and over
Contact the trial teamBrain scans with a tracer to study astrocyte changes in dementia diseases
2025-523284-37-00 · EU Clinical Trials Register
Countries: Spain
- Barcelona, Spain – Hospital Clinic de Barcelona
- Barcelona, Spain – Barcelonabeta Brain Research Center
- Barcelona, Spain – Hospital de la Santa Creu i Sant Pau
Age 18 and over
Contact the trial teamBlood Markers of Brain Inflammation Across Stages of Alzheimer's Disease
NCT07803055 · ClinicalTrials.gov
Countries: Italy
- Rome, Italy – Fondazione Policlinico Agostino Gemelli IRCCS
Ages 55 to 80
Contact the trial teamSpeech-based AI tool to detect dementia in Danish patients
NCT07200739 · ClinicalTrials.gov
Countries: Denmark
- Roskilde, Denmark – Zealand University Hospital
Age 50 and over
Contact the trial teamOnline study of APOE gene types and Alzheimer's disease risk in adults
NCT07679906 · ClinicalTrials.gov
Countries: France
- Huningue, France – FIRALIS SA - Centre de Prélèvements Biologiques
Age 45 and over
Contact the trial teamTests a new PET scan tracer for TDP-43 protein in the brain
NCT06891716 · ClinicalTrials.gov
Countries: Netherlands
- Amsterdam, Netherlands – Amsterdam UMC
Ages 40 to 70
Contact the trial teamGut Methane and Parkinson's Disease: Breath Tests and a Probiotic
NCT07786116 · ClinicalTrials.gov
Countries: United Kingdom
- Cambridge, United Kingdom – John Van Geest Centre for Brain Repair - Forvie Site, Robinson Way
Age 55 and over
Contact the trial teamSafety of DNL921 in Healthy Adults and People With Alzheimer's Disease
NCT07758595 · ClinicalTrials.gov
Countries: United Kingdom
- Manchester, United Kingdom – Clinical Site(s)
Ages 18 to 75
Contact the trial teamTracing how brain fluid drains to neck lymph nodes in organ donors
NCT07682155 · ClinicalTrials.gov
Countries: Spain
- Badalona, Spain – Germans Trias i Pujol Universitary Hospital
No age limit given in the registry
Contact the trial teamStudies brain changes in older people with memory problems or Alzheimer disease
NCT06448403 · ClinicalTrials.gov
Countries: Norway
- Trondheim, Norway – Norwegian University of Sciene and Technology / Norges teknisk-naturvitenskapelige universitet (NTNU)
Age 65 and over
Contact the trial teamStudying Memory Loss in Alzheimer Disease Using Brain Scans and Tests
NCT07118137 · ClinicalTrials.gov
Countries: Norway
- Trondheim, Norway – Norwegian University of Sciene and Technology / Norges teknisk-naturvitenskapelige universitet (NTNU)
Age 55 and over
Contact the trial teamAn online storytelling programme for people with dementia and their carers
NCT07757178 · ClinicalTrials.gov
Countries: United Kingdom
- Nottingham, United Kingdom – Nottinghamshire Healthcare NHS Foundation , Highbury Hospital
- Nottingham, United Kingdom – Mental Health & Clinical Neurosciences, Institute of Mental Health
Ages 18 to 99
Contact the trial teamUsing Movement and Imagined Movement to Help Memory in Alzheimer's Disease
NCT07632755 · ClinicalTrials.gov
Countries: France
- Grenoble, France – Chu Grenoble
- Saint-Etienne, France – Chu de Saint Etienne
- Villeurbanne, France – HLC, Hôpital des Charpennes
Age 60 and over
Contact the trial teamTests remternetug in people with an Alzheimer's-causing gene mutation
NCT05552157 · ClinicalTrials.gov
Countries: Germany, Spain, France and 11 more
- Munich, Germany – LMU-Campus Grosshadern
- Tübingen, Germany – Universitaetsklinikum Tubingen
- Barcelona, Spain – Hospital Clínic i Provincial de Barcelona
Age 18 and over
Contact the trial teamTests remternetug in people at risk for early-onset familial Alzheimer disease
NCT06647498 · ClinicalTrials.gov
Countries: Germany, Spain, France and 11 more
- Munich, Germany – LMU-Campus Grosshadern
- Tübingen, Germany – Universitaetsklinikum Tubingen
- Barcelona, Spain – Hospital Clínic i Provincial de Barcelona
Age 18 and over
Contact the trial teamEye scans to help diagnose and monitor multiple sclerosis, Alzheimer's, Parkinson's and headache disorders
NCT07720765 · ClinicalTrials.gov
Countries: Italy
- Milan, Italy – IRCCS Ospedale San Raffaele - Neurology and Neurophysiology Unit
Age 18 and over
Contact the trial teamBrain Scans and Eye Tests for Early Alzheimer's Changes in Older Adults
NCT07007208 · ClinicalTrials.gov
Countries: France
- Toulouse, France – University Hospital of Toulouse
Ages 60 to 100
Contact the trial teamBlood tests for Alzheimer's disease in people with memory concerns seen by family doctors
NCT07666113 · ClinicalTrials.gov
Countries: Belgium
- Leuven, Belgium – UZ Leuven/KU Leuven
Ages 55 to 85
Contact the trial teamTesting an Italian version of a questionnaire on activity levels in older adults
NCT07533084 · ClinicalTrials.gov
Countries: Italy
- Brescia, Italy – IRCCS Centro San Giovanni di Dio Fatebenefratelli
- Genova, Italy – IRCCS San Martino
- Milan, Italy – IRCCS Istituto Neurologico Carlo Besta
Age 65 and over
Contact the trial teamSpeech Therapy in Both Languages for Bilingual Adults With Primary Progressive Aphasia
NCT05741853 · ClinicalTrials.gov
Countries: Spain, United States
- Barcelona, Spain – Hospital Clinic de Barcelona
- Barcelona, Spain – Hospital de la Santa Creu i Sant Pau
- Austin, United States – University of Texas at Austin
Age 40 and over
Contact the trial teamA French Questionnaire to Assess Spatial Orientation Problems in Alzheimer's Disease
NCT07616063 · ClinicalTrials.gov
Countries: France
- Nancy, France – CHRU (Centre Hospitalier Régionale Universitaire) Nancy
Ages 18 to 85
Contact the trial teamStudying slowed movement and brain changes in people with Alzheimer's disease
NCT02811653 · ClinicalTrials.gov
Countries: France
- Amiens, France – CHU Amiens
Ages 40 to 85
Contact the trial teamA Monument Naming Test to Compare Memory in Alzheimer's Disease and Healthy Older Adults
NCT07367880 · ClinicalTrials.gov
Countries: France
- Grenoble, France – CHU Grenoble Alpes
Ages 50 to 95
Contact the trial teamComparing a new high-detail brain PET scanner with standard PET/CT scans
NCT07595666 · ClinicalTrials.gov
Countries: Belgium
- Leuven, Belgium – UZ Leuven
Age 0 and over
Contact the trial teamStudies how brain cells that regulate hormones relate to dementia
NCT05288842 · ClinicalTrials.gov
Countries: France
- Lille, France – Memory Resources and Research Center Lille
Ages 40 to 85
Contact the trial teamImaging brain amyloid and glucose use in people enrolled in the ALFA project
2024-519961-23-00 · EU Clinical Trials Register
Countries: Spain
- Barcelona, Spain – Barcelonabeta Brain Research Center
Age 18 and over
Contact the trial team
Showing 40 of 370. Use the filters to narrow the list.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- In peopleSex-stratified associations between the triglyceride-glucose index and urinary AD7c-NTP levels in adults: a cross-sectional study.Ann Med · 2026-11-17
- ReviewDietary and endogenous fructose metabolism in Alzheimer's disease: a critical review of mechanistic, preclinical, and epidemiological evidence.Metab Brain Dis · 2026-11-17
- Global, regional, and national burden of Alzheimer's disease and other dementias with a focus on populations aged 40 years and older, 1990-2023, and projections to 2040: a systematic analysis based on the Global Burden of Disease Study 2023.Neuroepidemiology · 2026-11-17
- Novel Compounds as TREM2 Agonists for Treating Parkinson's Disease, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Nasu-Hakola Disease, and Stroke.ACS Med Chem Lett · 2026-10-09
- Correction: Self-organizing 3D human neural tissue derived from induced pluripotent stem cells recapitulate Alzheimer's disease phenotypes.PLoS One · 2026-11-17
Is it true?
Saw something on social media? Fact-check it now.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Alzheimer Austria
Self-help organisation for 35+ years: free confidential counselling by appointment (alzheimeraustria@aon.at), young-onset group, peer counselling, partner and adult-children groups, Alzheimer Cafe, carer course.
- Demenz Selbsthilfe Austria
Federation and umbrella organisation of dementia self-help groups in Austria (founded 2021); Alzheimer Europe full member.
- Demenzstrategie „Gut leben mit Demenz“
Public portal of Austria's national dementia strategy with material for people with dementia and relatives and links to regional services.
- Fonds Demenzhilfe Österreich (Volkshilfe Demenzhilfe)
Volkshilfe initiative giving financial aid to people with dementia at risk of poverty; information on counselling, self-help groups and care services.
- MAS Alzheimerhilfe
Dementia service points (information and practical help for people with dementia and relatives), guided self-help groups, Alzheimer holiday for couples, carer tips.
Phone: +43 6132 214 10
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (9)
- Alzheimer's Association
Free 24/7 Helpline (interpreters for 200+ languages), care consultations with dementia experts, local chapters, Community Resource Finder, ALZConnected online community.
- Alzheimer's Drug Discovery Foundation
Funds the early work on new Alzheimer's medicines, in universities and companies.
Phone: 212.901.8000
- BrightFocus Foundation
US nonprofit that funds research and provides public information on Alzheimer's disease, macular degeneration and glaucoma.
- Dementia Alliance International (DAI)
Organisation for people with a dementia diagnosis: free online peer support groups, webinars, Brain Health Hub, resources for care partners.
- Alzheimer Europe
Umbrella of national Alzheimer associations in 39 countries, with a member directory.
- Alzheimer's Disease International (ADI)
Global federation of dementia associations in 100+ countries: member associations list, find local support, dementia information, World Alzheimer Report.
- European Federation of Neurological Associations (EFNA)
Umbrella of 21 pan-European neurology patient groups; map of European neurology patient organisations.
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.